WallStreetZenWallStreetZen

NASDAQ: CLPT
Clearpoint Neuro Inc Stock

$6.80+0.08 (+1.19%)
Updated Mar 28, 2024
CLPT Price
$6.80
Fair Value Price
N/A
Market Cap
$183.44M
52 Week Low
$4.05
52 Week High
$10.95
P/E
-7.56x
P/B
8.66x
P/S
6.97x
PEG
N/A
Dividend Yield
N/A
Revenue
$23.96M
Earnings
-$22.09M
Gross Margin
56.8%
Operating Margin
-93.82%
Profit Margin
-92.2%
Debt to Equity
1.02
Operating Cash Flow
-$14M
Beta
1.12
Next Earnings
May 9, 2024
Ex-Dividend
N/A
Next Dividend
N/A

CLPT Overview

ClearPoint Neuro, Inc. is a medical device company developing platforms for performing minimally invasive surgical procedures in the brain under direct and intra-procedural magnetic resonance imaging (MRI ) guidance. It offers the ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters, into the brain. The ClearPoint Neuro Navigation System is an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, and others. ClearPoint Neuro was incorporated in 1998 and is headquartered in Solana Beach, CA.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CLPT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLPT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLPT is poor value based on its book value relative to its share price (8.66x), compared to the US Medical Devices industry average (4.11x)
P/B vs Industry Valuation
CLPT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more CLPT due diligence checks available for Premium users.

Be the first to know about important CLPT news, forecast changes, insider trades & much more!

CLPT News

Valuation

CLPT fair value

Fair Value of CLPT stock based on Discounted Cash Flow (DCF)
Price
$6.80
Fair Value
-$0.02
Undervalued by
32,298.18%
CLPT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLPT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-7.56x
Industry
29.92x
Market
44.51x

CLPT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
8.66x
Industry
4.11x
CLPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLPT's financial health

Profit margin

Revenue
$6.8M
Net Income
-$4.6M
Profit Margin
-67.8%
CLPT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CLPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$42.7M
Liabilities
$21.5M
Debt to equity
1.02
CLPT's short-term assets ($36.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLPT's short-term assets ($36.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLPT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.2M
Investing
-$188.0k
Financing
$155.0k
CLPT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CLPT vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
CLPT$183.44M+1.19%-7.56x8.66x
QIPT$183.99M+0.69%-65.22x2.25x
PROF$182.29M+3.02%-8.59x7.95x
INGN$188.25M+1.32%-1.83x0.92x
SMLR$205.38M+2.31%9.55x2.86x

Clearpoint Neuro Stock FAQ

What is Clearpoint Neuro's quote symbol?

(NASDAQ: CLPT) Clearpoint Neuro trades on the NASDAQ under the ticker symbol CLPT. Clearpoint Neuro stock quotes can also be displayed as NASDAQ: CLPT.

If you're new to stock investing, here's how to buy Clearpoint Neuro stock.

What is the 52 week high and low for Clearpoint Neuro (NASDAQ: CLPT)?

(NASDAQ: CLPT) Clearpoint Neuro's 52-week high was $10.95, and its 52-week low was $4.05. It is currently -37.9% from its 52-week high and 67.9% from its 52-week low.

How much is Clearpoint Neuro stock worth today?

(NASDAQ: CLPT) Clearpoint Neuro currently has 26,976,289 outstanding shares. With Clearpoint Neuro stock trading at $6.80 per share, the total value of Clearpoint Neuro stock (market capitalization) is $183.44M.

Clearpoint Neuro stock was originally listed at a price of $30.00 in May 22, 2012. If you had invested in Clearpoint Neuro stock at $30.00, your return over the last 11 years would have been -77.33%, for an annualized return of -12.62% (not including any dividends or dividend reinvestments).

How much is Clearpoint Neuro's stock price per share?

(NASDAQ: CLPT) Clearpoint Neuro stock price per share is $6.80 today (as of Mar 28, 2024).

What is Clearpoint Neuro's Market Cap?

(NASDAQ: CLPT) Clearpoint Neuro's market cap is $183.44M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Clearpoint Neuro's market cap is calculated by multiplying CLPT's current stock price of $6.80 by CLPT's total outstanding shares of 26,976,289.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.